(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one

(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Suppliers list
Company Name: China National Standard Pharmaceutical Corporation Limited
Tel: +8615391658522
Email: overseasales@yongstandards.com
Products Intro: Product Name:Teprenone Impurity 8
CAS:3879-24-1
Purity:0.95 Package:Vials
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Products Intro: Product Name:Teprenone Impurity 4
CAS:3879-24-1
Purity:> 95% Remarks:One impurity of Teprenone, which could be used as an anti-ulcerative agent and has been found to ind
Company Name: BOC Sciences  
Tel: 16314854226
Email: info@bocsci.com
Products Intro: Product Name:Teprenone Impurity 4
CAS:3879-24-1
Purity:>95%
Company Name: QUALITY CONTROL SOLUTIONS LTD.  
Tel: 13670046396
Email: ORDERS@QCSRM.COM
Products Intro: Product Name:Teprenone Impurity 7
CAS:3879-24-1
Purity:95% HPLC Package:10MG;25MG;50MG;100MG
Company Name: Cato Research Chemicals Inc.  
Tel: 020-81960175-877 18933936954
Email: tianwen.zhan@cato-chem.com
Products Intro: Product Name:(5Z,9Z,13E)-Teprenone
CAS:3879-24-1
Purity:>95% Package:10mg
(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Basic information
Product Name:(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
Synonyms:(5Z,9Z,13E)-Geranylgeranylacetone;(5Z,9Z,13E)-Teprenone
CAS:3879-24-1
MF:C23H38O
MW:330.54722
EINECS:
Product Categories:
Mol File:3879-24-1.mol
(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Structure
(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Chemical Properties
Safety Information
MSDS Information
(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Usage And Synthesis
Uses(5Z,9Z,13E)-Geranylgeranylacetone is the structural analogue of Teprenone (T103500), an anti-ulcerative. Geranylgeranylacetone can induce expression of HSP70, HSPB8, and HSPB1. Induction of HSP70 expression is protective against the development of various diseases, such as inflammatory bowel disease, hypoxic/ischemic brain injury and spinal and bulbar muscular atrophy (cytoprotective and anti-inflammatory effects). Reports indicate that GGA protects against NSAID-induced gastric and intestinal lesions by induction of HSP70 expression. Other studies have shown that GGA induces expression of HSPB8 and HSPB1 and reduces the formation of amyloid oligomers as well as insoluble aggregates in HSPB5 R120G TG mice.
(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Preparation Products And Raw materials
Tag:(5Z,9Z,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one(3879-24-1) Related Product Information